Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma.

R Mercieca-BebberE H BarnesK WilsonZ SamoonE WalpoleT MaiS AcklandM BurgeG DickieD WatsonJ LeungT WangR BohmerD CameronJ SimesV GebskiM SmithersJ ThomasJ ZalcbergRebecca Mercieca-Bebber

Published in: BMC cancer (2022)

Australia New Zealand Clinical Trials Registry (ANZCTR), ACTRN12609000665235 . Registered 31 July 2009.

Keyphrases

clinical trial
patient reported outcomes
locally advanced
rectal cancer
phase ii
phase iii
squamous cell carcinoma
open label
study protocol
radiation therapy
double blind
anti inflammatory
smoking cessation
placebo controlled
lymph node
randomized controlled trial
liver metastases